Shares of Allergan plc Ordinary Shares (NYSE:AGN) ended Friday session in red amid volatile trading. The shares closed down -1.80 points or -0.76% at $235.96 with 2.82 million shares getting traded. Post opening the session at $237.50, the shares hit an intraday low of $234.35 and an intraday high of $238.03 and the price vacillated in this range throughout the day. The company has a market cap of $94.14 billion and the numbers of outstanding shares have been calculated to be 395.95 million shares.
Allergan plc Ordinary Shares (AGN) announced that Brent Saunders, Allergan’s CEO and President, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 at 11:45 a.m. ET at the Grand Hyatt in New York, NY.
The presentation will be webcast live and can be accessed on Allergan’s Investor Relations web site at http://ir.allergan.com.
An archived version will be available approximately two hours after the live presentation ends and can be accessed at the same locations for 180 days.
Shares of Quintiles Transnational Holdings Inc (NYSE:Q) ended Friday session in red amid volatile trading. The shares closed down -0.46 points or -0.59% at $76.96 with 359,684.00 shares getting traded. Post opening the session at $77.46, the shares hit an intraday low of $76.85 and an intraday high of $77.78 and the price vacillated in this range throughout the day. The company has a market cap of $9.13 billion and the numbers of outstanding shares have been calculated to be 118.48 million shares.
On August 29, 2016 IMS Health Holdings, Inc. (IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q) announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to the completion of the merger.
Senior functional leaders reporting to Chairman and Chief Executive Officer Ari Bousbib will include Michael McDonnell, EVP and Chief Financial Officer; James Erlinger, EVP and General Counsel; and Trudy Stein, EVP and Chief Human Resources Officer.
Global business leaders reporting to Mr. Bousbib will include, for the clinical research business, Tom Pike, Vice Chairman and President, Research & Development Solutions; and for the commercial business, Kevin Knightly, President, Information and Technology Solutions; José Luis Fernández, President, Global Services; Jon Resnick, President, Real-World Insights; and Scott Evangelista, President, Contract Sales Organization.
“I am proud to be part of a leadership team with deep industry knowledge, a proven track record of success and a commitment to transforming healthcare for the better,” said Ari Bousbib. “That commitment extends across the 50,000 talented professionals who will soon become part of one global team. Together, we are making excellent progress on our integration planning and are confident that we will be ready for a strong start on day one of the merger.”